Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
about
Dopamine release in the basal gangliaLower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primatesA practical guide to the therapy of narcolepsy and hypersomnia syndromesThe use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorderNeurocircuitry of addictionFaster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeysMethylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersRole of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuseLess Effort, Better Results: How Does Music Act on Prefrontal Cortex in Older Adults during Verbal Encoding? An fNIRS StudySerotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockoutDopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attentionBehavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.A linear model for estimation of neurotransmitter response profiles from dynamic PET data.Methylphenidate off-label use and safety.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Sex, ADHD symptoms, and smoking outcomes: an integrative model.Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based studyRelationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeysDopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidateMethylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorderRapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuliMethylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorderCatecholamine influences on dorsolateral prefrontal cortical networks.Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidateClinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.Dissociable roles of dopamine and serotonin transporter function in a rat model of negative urgency.Effect of methylphenidate on mismatched visual information processing in young healthy volunteers: an event-related potential study.Addiction and brain reward and antireward pathways.Individual differences in impulsive action and dopamine transporter function in rat orbitofrontal cortex.Stimulants: Therapeutic actions in ADHD.Oral administration of methylphenidate blocks the effect of cocaine on uptake at the Drosophila dopamine transporter.The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults.Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder.Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry.An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.
P2860
Q22251247-0A202E88-9817-45FE-B82B-AF0F042B8526Q24605771-5F372620-6969-47E6-83E0-6EC389656963Q24623713-80E786FA-8666-4048-AC79-A2BDAAF338FEQ24629736-3BB24A5E-CA1B-44BB-BEF1-F44125B8A019Q24647156-06305565-DC32-4A21-82B6-6070311881B7Q24685831-B5AF0C2B-03BF-4F88-9DE6-E6AFB09C11E1Q24810310-5896026B-DE98-4BB4-9139-88CE69083C05Q28284151-703DEBCA-D5A6-4724-B030-8957A6C54D0CQ28306056-E070D67F-B58D-449E-B0CB-7EDE21D8833FQ30362855-2180D7B7-F223-4B8B-BD14-C087B1577EA0Q30422443-4571CE37-E926-4645-831A-921EDAC25CE5Q30488704-8992903E-BA82-40BC-A2CE-CF01E7FE6969Q33624591-7F467116-A277-4FBA-9C99-0A2F4137B87DQ33799533-50E4882D-B885-4205-8B37-CD6E793C0A88Q33964638-8B9611B8-4D88-465F-B50F-86EC3CD0DA67Q34172165-B27114B8-CA60-4966-92E5-EC3B23918BE1Q34253787-B430C416-DF8C-4A7A-9D20-79242C72F123Q34255025-ED067DF5-7D6A-4565-9FCF-6918A49DA492Q34397750-0AF73AB5-F111-4FF3-B629-C360FB378271Q34466098-856AD547-18A3-41FF-8E44-EAC2EAB0C74AQ34777680-9609CA06-8E5E-47B5-B8F7-EE27CFF3012AQ34991378-8B8ED0DB-BF03-4B67-A657-ACF7582F2FCBQ35050238-1CABFA17-96A5-4AF7-8F7B-F9C1DB326596Q35085890-F0CB7F26-F537-47E7-816B-4F4403FE5882Q35116217-006BA7E4-0903-4893-B776-3C0A65615743Q35132548-5C1CBB50-C195-4AB2-B453-AA462FF7C7A5Q35534241-F26B19F7-22C6-4898-A9C4-9EDBD97595D0Q35766564-C9440954-D2F4-4331-ACA0-75F88915EAA8Q35836379-1550CD96-0283-4527-9D18-AC5DE5498737Q35959453-8A0E24C4-C286-4CBB-B169-620FD3D114F6Q35995170-F2C67F0B-4086-4AE3-A364-6B77D05018C3Q36414711-CCC716AA-33BD-4E51-8003-D45BF6732D1FQ36541590-0E740068-A502-4F3D-9041-500F81397962Q36776393-2659F572-1FC3-4016-8EB1-F1B04A445638Q36805793-09FBE66B-046D-49C7-BA01-157AA52FE8BCQ37010911-DF6D414A-A839-40B8-8CFF-8140B2398401Q37056071-79C67781-0136-4D90-8291-C2FD60E0BF0BQ37183477-CD546754-9B23-4BE0-9CE3-EF6A9DBE7221Q37613424-48E9148E-5516-4F94-A543-36727324BC26Q38214174-C32CE5AE-FD37-4CA2-A2C9-BB504E97DF6F
P2860
Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Role of dopamine in the therap ...... results from imaging studies.
@ast
Role of dopamine in the therap ...... results from imaging studies.
@en
Role of dopamine in the therap ...... results from imaging studies.
@nl
type
label
Role of dopamine in the therap ...... results from imaging studies.
@ast
Role of dopamine in the therap ...... results from imaging studies.
@en
Role of dopamine in the therap ...... results from imaging studies.
@nl
prefLabel
Role of dopamine in the therap ...... results from imaging studies.
@ast
Role of dopamine in the therap ...... results from imaging studies.
@en
Role of dopamine in the therap ...... results from imaging studies.
@nl
P2093
P1476
Role of dopamine in the therap ...... results from imaging studies.
@en
P2093
Gene Jack Wang
Joanna S Fowler
Nora D Volkow
Samuel J Gatley
Yu Shin Ding
P304
P356
10.1016/S0924-977X(02)00104-9
P407
P577
2002-12-01T00:00:00Z